Search results
Vertex Pharmaceuticals (NASDAQ:VRTX) Upgraded by StockNews.com to “Strong-Buy”
ETF DAILY NEWS· 5 days agoJPMorgan Chase & Co. boosted their target price on Vertex Pharmaceuticals from $390.00 to $438.00 and gave the stock an overweight rating in a research ...
Massachusetts Financial Services Co. MA Sells 2,435 Shares of Catalyst Pharmaceuticals, Inc....
ETF DAILY NEWS· 4 days agoThe firm owned 77,128 shares of the biopharmaceutical company’s stock after selling 2,435 shares during the quarter. Massachusetts Financial Services Co. MA owned about 0.07% ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 21 hours agoTSX Venture Exchange Stock Maintenance Bulletins Canada NewsWire VANCOUVER, BC, May 23, 2024 VANCOUVER, BC, May 23, 2024 /CNW/ - TSX VENTURE COMPANIES BULLETIN V2024-1547 ...
3 S&P 500 Stocks That Have Proven Themselves Recession-Proof
InvestorPlace· 4 days agoSince 1928, there have been 25 bear markets, or declines in the S&P 500 of 20% or more, according to...
European stocks fall in Fed rate concerns; AstraZeneca lifts revenue target By Investing.com
Investing.com· 4 days agoEuropean stock markets slipped lower Tuesday, as the positive momentum at the start of the week...
ESSA Pharma’s (EPIX) Outperform Rating Reiterated at Oppenheimer
ETF DAILY NEWS· 6 days agoOppenheimer reiterated their outperform rating on shares of ESSA Pharma (NASDAQ:EPIX – Free Report) (TSE:EPI) in a research report sent to investors on Thursday morning, Benzinga reports. Oppenheimer ...
7 Dividend Kings to Buy for Royal Passive Income: May Edition
InvestorPlace· 3 days agoFundamentally, the case for dividend kings to buy couldn’t be simpler: investors are banking on the...
Johnson & Johnson's Dividend Analysis
Guru Focus· 5 days agoJohnson & Johnson (JNJ, Financial) recently announced a dividend of $1.24 per share, payable on 2024-06-04, with the ex-dividend date set for 2024-05-20. As investors look forward to this upcoming ...
Q3 2024 EPS Estimates for Sanofi (NASDAQ:SNY) Increased by Analyst
ETF DAILY NEWS· 3 days agoSanofi (NASDAQ:SNY – Free Report) – Research analysts at Zacks Research raised their Q3 2024 EPS estimates for Sanofi in a report released on Thursday, May 16th. Zacks Research analyst K. Shah ...